Rational Design of Pyrazole–Chalcone Congeners via Enumeration: Insights From Molecular Docking, MM‐GBSA, Pharmacophore Modelling, MD Simulations and DFT Calculations
Journal of Chemistry · 2026-01 · 2026 (1)
DOI: 10.1155/joch/2679860 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemistry, online erschienen am 21.05.2026. Verfasst von Zakiya Fathima C. und 4 weiteren Autor:innen. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Monoamine oxidase‐B (MAO‐B) is a pivotal enzyme in the pathophysiology of Parkinson’s disease (PD), where its elevated activity accelerates dopamine catabolism, increases oxidative stress and contributes to the progressive loss of dopaminergic neurons. This study investigates the MAO‐B inhibitory potential of a series of pyrazole‐based chalcone derivatives using an integrated computational framework.
Methods
A ligand library was generated through R‐group enumeration and screened for physicochemical suitability and pharmacokinetic compliance. Molecular docking against MAO‐B (PDB ID: 2BYB) was performed to evaluate binding affinity, which was further validated through MM‐GBSA binding free‐energy calculations. Pharmacophore modelling using Phase identified the key structural features governing MAO‐B inhibition. The top‐ranked complexes were subjected to molecular dynamics simulations to assess structural stability. Density functional theory (DFT) calculations were conducted to examine electronic reactivity, including HOMO–LUMO gaps and related quantum descriptors.
Results
The designed ligands demonstrated favourable physicochemical and pharmacokinetic profiles. Docking studies indicated strong binding affinities, with several compounds outperforming the reference inhibitor deprenyl, consistent with MM‐GBSA predictions. Pharmacophore modelling revealed a five‐point AHHRR_1 hypothesis as the critical determinant of activity. Hydrophobic 3,5‐dimethyl substitutions on the pyrazole ring enhanced electron density and inhibitory potency, while the conjugated π‐system between pyrazole and phenyl moieties contributed to stabilised π–π interactions. Para‐substituted electron‐withdrawing groups on the phenyl ring further improved MAO‐B selectivity. Molecular dynamics simulations confirmed robust complex stability, with the 5b/2BYB complex exhibiting low RMSD, minimal residue fluctuations and persistent hydrogen‐bonding and hydrophobic contacts. DFT analysis revealed narrow HOMO–LUMO gaps, indicative of high electronic reactivity and strong binding propensity.
Conclusion
Overall, this comprehensive computational investigation offers valuable insights for the rational design and optimisation of pyrazole–chalcone derivatives as promising MAO‐B inhibitors for PD therapy and supports their further in vitro and in vivo evaluation.
Zitieren
APA
C., Z. F., James, J. P., Ganjipete, S., Pavadai, P., & J., S. T. (2026). Rational Design of Pyrazole–Chalcone Congeners via Enumeration: Insights From Molecular Docking, MM‐GBSA, Pharmacophore Modelling, MD Simulations and DFT Calculations. Journal of Chemistry, 2026(1). https://doi.org/10.1155/joch/2679860
Vancouver
C. ZF, James JP, Ganjipete S, Pavadai P, J. ST. Rational Design of Pyrazole–Chalcone Congeners via Enumeration: Insights From Molecular Docking, MM‐GBSA, Pharmacophore Modelling, MD Simulations and DFT Calculations. Journal of Chemistry. 2026;2026(1). doi:10.1155/joch/2679860
BibTeX
@article{C2026,
author = {C., Zakiya Fathima and James, Jainey P. and Ganjipete, Srinivas and Pavadai, Parasuraman and J., Sindhu T.},
title = {Rational Design of Pyrazole–Chalcone Congeners via Enumeration: Insights From Molecular Docking, MM‐GBSA, Pharmacophore Modelling, MD Simulations and DFT Calculations},
journal = {Journal of Chemistry},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/joch/2679860}
}
EUVIMED